The neuronal ceroid lipofuscinoses (CLN) are a group of conditions that are inherited in an autosomal recessive pattern. CLN2, also known as late-infantile or LICLN, generally begins with the onset of seizures between the ages of 2 to 4 years. Developmental regression follows including speech and motor problems along with cognitive decline. In addition to specific findings on EEG and evoked potentials, neurological deterioration is evidenced by ataxia and myoclonus. Retinal degeneration leads to progressive vision loss and ultimately, blindness. The lipopigment pattern seen in CLN2 under microscopic evaluation is said to be curvilinear. Death usually occurs by 10-15 years of age.